313 related articles for article (PubMed ID: 32902200)
21. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials.
Maneeton N; Maneeton B; Srisurapanont M; Martin SD
BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200
[TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
J Affect Disord; 2020 May; 269():154-184. PubMed ID: 32339131
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
Findling RL; Pathak S; Earley WR; Liu S; DelBello MP
J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
[TBL] [Abstract][Full Text] [Related]
25. Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.
Gao K; Kemp DE; Fein E; Wang Z; Fang Y; Ganocy SJ; Calabrese JR
J Clin Psychiatry; 2011 Aug; 72(8):1063-71. PubMed ID: 21034695
[TBL] [Abstract][Full Text] [Related]
26. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression.
Kato T; Ishigooka J; Miyajima M; Watabe K; Fujimori T; Masuda T; Higuchi T; Vieta E
Psychiatry Clin Neurosci; 2020 Dec; 74(12):635-644. PubMed ID: 32827348
[TBL] [Abstract][Full Text] [Related]
28. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
[TBL] [Abstract][Full Text] [Related]
29. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
[TBL] [Abstract][Full Text] [Related]
30. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
[TBL] [Abstract][Full Text] [Related]
31. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
[TBL] [Abstract][Full Text] [Related]
32. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
33. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
Suppes T; Kroger H; Pikalov A; Loebel A
J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
[TBL] [Abstract][Full Text] [Related]
34. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
[No Abstract] [Full Text] [Related]
35. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
Tocco M; Mao Y
J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):345-352. PubMed ID: 38639433
[TBL] [Abstract][Full Text] [Related]
36. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N
Mol Psychiatry; 2021 Aug; 26(8):4146-4157. PubMed ID: 33177610
[TBL] [Abstract][Full Text] [Related]
37. Balancing benefits and harms of treatments for acute bipolar depression.
Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L
J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
Yildiz A; Siafis S; Mavridis D; Vieta E; Leucht S
Lancet Psychiatry; 2023 Sep; 10(9):693-705. PubMed ID: 37595997
[TBL] [Abstract][Full Text] [Related]
39. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
[TBL] [Abstract][Full Text] [Related]
40. Lurasidone Dose Response in Bipolar Depression: A Population Dose-response Analysis.
Chapel S; Chiu YY; Hsu J; Cucchiaro J; Loebel A
Clin Ther; 2016 Jan; 38(1):4-15. PubMed ID: 26730454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
